Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The price of Alignment Healthcare Inc (NASDAQ: ALHC) closed at $17.18 in the last session, down -0.06% from day before closing price of $17.19. In other words, the price has decreased by -$0.06 from its previous closing price. On the day, 2.3 million shares were traded. ALHC stock price reached its highest trading level at $17.375 during the session, while it also had its lowest trading level at $16.72.
Ratios:
We take a closer look at ALHC’s different ratios to gain a better understanding of the stock. In the meantime, Its Debt-to-Equity ratio is 3.39 whereas as Long-Term Debt/Eq ratio is at 3.38.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stephens on December 03, 2024, Upgraded its rating to Overweight and sets its target price to $17 from $13 previously.
BofA Securities Upgraded its Neutral to Buy on May 30, 2024, whereas the target price for the stock was revised from $7.75 to $11.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 20 ’25 when HYONG J KIM bought 26,734 shares for $17.19 per share.
Wagner Andreas P. sold 7,632 shares of ALHC for $125,172 on Mar 19 ’25. The Chief Human Resources Officer now owns 223,474 shares after completing the transaction at $16.40 per share. On Mar 18 ’25, another insider, Wagner Andreas P., who serves as the Chief Human Resources Officer of the company, sold 4,888 shares for $16.89 each. As a result, the insider received 82,561 and left with 231,106 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALHC now has a Market Capitalization of 3295673856 and an Enterprise Value of 3156608512. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.22 while its Price-to-Book (P/B) ratio in mrq is 33.00. Its current Enterprise Value per Revenue stands at 1.168 whereas that against EBITDA is -44.202.
Stock Price History:
The Beta on a monthly basis for ALHC is 1.40, which has changed by 2.6398306 over the last 52 weeks, in comparison to a change of 0.08190584 over the same period for the S&P500. Over the past 52 weeks, ALHC has reached a high of $17.27, while it has fallen to a 52-week low of $4.46. The 50-Day Moving Average of the stock is 16.91%, while the 200-Day Moving Average is calculated to be 51.19%.
Shares Statistics:
According to the various share statistics, ALHC traded on average about 2.12M shares per day over the past 3-months and 2774710 shares per day over the past 10 days. A total of 191.78M shares are outstanding, with a floating share count of 107.66M. Insiders hold about 43.88% of the company’s shares, while institutions hold 56.44% stake in the company. Shares short for ALHC as of 1740700800 were 7050837 with a Short Ratio of 3.33, compared to 1738281600 on 8054907. Therefore, it implies a Short% of Shares Outstanding of 7050837 and a Short% of Float of 5.74.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
